Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by STOLPER MARK, Director. Director active across 2 companies, notably Surgalign Holdings, INC.. Cumulatively, 12 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €1.4m. History available since 7 May 2021. The latest transaction was filed on 8 January 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Mark Stolper is a Board Member at Surgalign Holdings, Inc. He plays a key role in the governance of the company, providing his experience and expertise to guide strategic decisions and ensure compliance with governance standards.